Published • loading... • Updated
Covid: a Clinical Trial Validates an Oral Antiviral that Reduces the Risk After Exposure by 67%
Summary by Science-Et-vie.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Preventing covid after exposure to an infected relative has just become possible. An oral antiviral reduces the risk of contamination by 67% in five days of treatment. It is a world first. A global trial proves that covid can be prevented after exposure to the home Since the beginning of the pandemic, no oral drugs were used to prevent covid in exposed contacts. The SCORPIO-PEP study has just changed the situation. Indeed, it is the first phase …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
